Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Gain-of-function mutations in DNMT3A in patients with paraganglioma.

Remacha L, Currás-Freixes M, Torres-Ruiz R, Schiavi F, Torres-Pérez R, Calsina B, Letón R, Comino-Méndez I, Roldán-Romero JM, Montero-Conde C, Santos M, Pérez LI, Pita G, Alonso MR, Honrado E, Pedrinaci S, Crespo-Facorro B, Percesepe A, Falcioni M, Rodríguez-Perales S, Korpershoek E, Ramón-Maiques S, Opocher G, Rodríguez-Antona C, Robledo M, Cascón A.

Genet Med. 2018 May 8. doi: 10.1038/s41436-018-0003-y. [Epub ahead of print]

PMID:
29740169
2.

The role of EZH2 in overall survival of colorectal cancer: a meta-analysis.

Vilorio-Marqués L, Martín V, Diez-Tascón C, González-Sevilla MF, Fernández-Villa T, Honrado E, Davila-Batista V, Molina AJ.

Sci Rep. 2017 Oct 23;7(1):13806. doi: 10.1038/s41598-017-13670-z.

3.

Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer-Predisposing Mutations in Pheochromocytomas and Paragangliomas.

Remacha L, Comino-Méndez I, Richter S, Contreras L, Currás-Freixes M, Pita G, Letón R, Galarreta A, Torres-Pérez R, Honrado E, Jiménez S, Maestre L, Moran S, Esteller M, Satrústegui J, Eisenhofer G, Robledo M, Cascón A.

Clin Cancer Res. 2017 Oct 15;23(20):6315-6324. doi: 10.1158/1078-0432.CCR-16-2250. Epub 2017 Jul 18.

PMID:
28720665
4.

Municipal distribution and trends in bladder cancer incidence in health area of León, Spain (1996-2010).

del Canto M, García-Martínez L, Fernández-Villa T, Molina AJ, Campanario F, García-Sanz M, López-Abente G, Honrado E, Martín-Sánchez V.

Actas Urol Esp. 2015 Jul-Aug;39(6):349-53. doi: 10.1016/j.acuro.2014.09.007. Epub 2015 Feb 11. English, Spanish.

PMID:
25682356
5.

Intraneural hybrid granular cell tumor-perineurioma.

Izquierdo FM, Suárez-Vilela D, Honrado E.

APMIS. 2013 Jul;121(7):678-80. doi: 10.1111/apm.12038. Epub 2012 Dec 20. No abstract available.

PMID:
23278335
6.

Perineurial cells in granular cell tumors and neoplasms with perineural invasion: an immunohistochemical study.

Izquierdo F, Suárez-Vilela D, Honrado E.

Am J Dermatopathol. 2012 Dec;34(8):800-9. doi: 10.1097/DAD.0b013e31824ba93b.

PMID:
22668577
7.

MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.

Burnichon N, Cascón A, Schiavi F, Morales NP, Comino-Méndez I, Abermil N, Inglada-Pérez L, de Cubas AA, Amar L, Barontini M, de Quirós SB, Bertherat J, Bignon YJ, Blok MJ, Bobisse S, Borrego S, Castellano M, Chanson P, Chiara MD, Corssmit EP, Giacchè M, de Krijger RR, Ercolino T, Girerd X, Gómez-García EB, Gómez-Graña A, Guilhem I, Hes FJ, Honrado E, Korpershoek E, Lenders JW, Letón R, Mensenkamp AR, Merlo A, Mori L, Murat A, Pierre P, Plouin PF, Prodanov T, Quesada-Charneco M, Qin N, Rapizzi E, Raymond V, Reisch N, Roncador G, Ruiz-Ferrer M, Schillo F, Stegmann AP, Suarez C, Taschin E, Timmers HJ, Tops CM, Urioste M, Beuschlein F, Pacak K, Mannelli M, Dahia PL, Opocher G, Eisenhofer G, Gimenez-Roqueplo AP, Robledo M.

Clin Cancer Res. 2012 May 15;18(10):2828-37. doi: 10.1158/1078-0432.CCR-12-0160. Epub 2012 Mar 27.

8.

Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.

Comino-Méndez I, Gracia-Aznárez FJ, Schiavi F, Landa I, Leandro-García LJ, Letón R, Honrado E, Ramos-Medina R, Caronia D, Pita G, Gómez-Graña A, de Cubas AA, Inglada-Pérez L, Maliszewska A, Taschin E, Bobisse S, Pica G, Loli P, Hernández-Lavado R, Díaz JA, Gómez-Morales M, González-Neira A, Roncador G, Rodríguez-Antona C, Benítez J, Mannelli M, Opocher G, Robledo M, Cascón A.

Nat Genet. 2011 Jun 19;43(7):663-7. doi: 10.1038/ng.861.

PMID:
21685915
9.

Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.

Melchor L, Saucedo-Cuevas LP, Muñoz-Repeto I, Rodríguez-Pinilla SM, Honrado E, Campoverde A, Palacios J, Nathanson KL, García MJ, Benítez J.

Breast Cancer Res. 2009;11(6):R86. doi: 10.1186/bcr2456. Epub 2009 Dec 8.

10.

[Sarcomatoid carcinoma in a patient with Sjögren's syndrome].

Rascarachi G, Honrado E, Quiroga Prado L.

Gastroenterol Hepatol. 2009 Mar;32(3):150-4. doi: 10.1016/j.gastrohep.2008.09.023. Epub 2009 Feb 20. Spanish.

PMID:
19231036
11.

Noncompliance with the world health organization-multidrug therapy among leprosy patients in Cebu, Philippines: its causes and implications on the leprosy control program.

Honrado ER, Tallo V, Balis AC, Chan GP, Cho SN.

Dermatol Clin. 2008 Apr;26(2):221-9, vi. doi: 10.1016/j.det.2007.11.007.

PMID:
18346553
12.

Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer.

Melchor L, Honrado E, Huang J, Alvarez S, Naylor TL, García MJ, Osorio A, Blesa D, Stratton MR, Weber BL, Cigudosa JC, Rahman N, Nathanson KL, Benítez J.

Clin Cancer Res. 2007 Dec 15;13(24):7305-13.

13.

Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.

Melchor L, Honrado E, García MJ, Alvarez S, Palacios J, Osorio A, Nathanson KL, Benítez J.

Oncogene. 2008 May 15;27(22):3165-75. Epub 2007 Dec 10.

PMID:
18071313
14.

Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer.

Leskelä S, Honrado E, Montero-Conde C, Landa I, Cascón A, Letón R, Talavera P, Cózar JM, Concha A, Robledo M, Rodríguez-Antona C.

Endocr Relat Cancer. 2007 Sep;14(3):645-54.

15.

Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families.

Honrado E, Osorio A, Milne RL, Paz MF, Melchor L, Cascón A, Urioste M, Cazorla A, Díez O, Lerma E, Esteller M, Palacios J, Benítez J.

Mod Pathol. 2007 Dec;20(12):1298-306. Epub 2007 Sep 21.

16.

Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas.

Cuadros M, Dave SS, Jaffe ES, Honrado E, Milne R, Alves J, Rodríguez J, Zajac M, Benitez J, Staudt LM, Martinez-Delgado B.

J Clin Oncol. 2007 Aug 1;25(22):3321-9. Epub 2007 Jun 18.

PMID:
17577022
17.

Classification of missense variants of unknown significance in BRCA1 based on clinical and tumor information.

Osorio A, Milne RL, Honrado E, Barroso A, Diez O, Salazar R, de la Hoya M, Vega A, Benítez J.

Hum Mutat. 2007 May;28(5):477-85.

PMID:
17279547
18.

Group A streptococcal septic vasculitis in a child with dengue hemorrhagic fever.

Vitug MR, Dayrit JF, Oblepias MS, Honrado ER.

Int J Dermatol. 2006 Dec;45(12):1458-61. No abstract available.

PMID:
17184265
19.

Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.

Rodríguez-Pinilla SM, Sarrió D, Honrado E, Moreno-Bueno G, Hardisson D, Calero F, Benítez J, Palacios J.

J Clin Pathol. 2007 Sep;60(9):1006-12. Epub 2006 Nov 14.

20.

Genomic analysis of the 8p11-12 amplicon in familial breast cancer.

Melchor L, Garcia MJ, Honrado E, Pole JC, Alvarez S, Edwards PA, Caldas C, Brenton JD, Benítez J.

Int J Cancer. 2007 Feb 1;120(3):714-7.

21.

Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations.

Honrado E, Osorio A, Palacios J, Benitez J.

Oncogene. 2006 Sep 25;25(43):5837-45. Review.

PMID:
16998498
22.

Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.

Pinilla SM, Honrado E, Hardisson D, Benítez J, Palacios J.

Breast Cancer Res Treat. 2006 Sep;99(1):85-90. Epub 2006 Mar 16.

PMID:
16541313
23.

Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas.

Rodríguez-Pinilla SM, Sarrió D, Honrado E, Hardisson D, Calero F, Benitez J, Palacios J.

Clin Cancer Res. 2006 Mar 1;12(5):1533-9.

24.

Histopathology of BRCA1- and BRCA2-associated breast cancer.

Honrado E, Benítez J, Palacios J.

Crit Rev Oncol Hematol. 2006 Jul;59(1):27-39. Epub 2006 Mar 10. Review.

PMID:
16530420
25.

The accumulation of specific amplifications characterizes two different genomic pathways of evolution of familial breast tumors.

Melchor L, Alvarez S, Honrado E, Palacios J, Barroso A, Díez O, Osorio A, Benítez J.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8577-84.

26.

Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas.

Martínez-Delgado B, Cuadros M, Honrado E, Ruiz de la Parte A, Roncador G, Alves J, Castrillo JM, Rivas C, Benítez J.

Leukemia. 2005 Dec;19(12):2254-63.

PMID:
16270046
27.

Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors.

Honrado E, Osorio A, Palacios J, Milne RL, Sánchez L, Díez O, Cazorla A, Syrjakoski K, Huntsman D, Heikkilä P, Lerma E, Kallioniemi A, Rivas C, Foulkes WD, Nevanlinna H, Benítez J.

J Clin Oncol. 2005 Oct 20;23(30):7503-11.

PMID:
16234517
28.

The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications.

Honrado E, Benítez J, Palacios J.

Mod Pathol. 2005 Oct;18(10):1305-20. Review.

29.

Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers.

Palacios J, Honrado E, Osorio A, Cazorla A, Sarrió D, Barroso A, Rodríguez S, Cigudosa JC, Diez O, Alonso C, Lerma E, Dopazo J, Rivas C, Benítez J.

Breast Cancer Res Treat. 2005 Mar;90(1):5-14.

PMID:
15770521
30.

A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation.

Alvarez S, Diaz-Uriarte R, Osorio A, Barroso A, Melchor L, Paz MF, Honrado E, Rodríguez R, Urioste M, Valle L, Díez O, Cigudosa JC, Dopazo J, Esteller M, Benitez J.

Clin Cancer Res. 2005 Feb 1;11(3):1146-53.

31.

A novel candidate region linked to development of both pheochromocytoma and head/neck paraganglioma.

Cascón A, Ruiz-Llorente S, Rodríguez-Perales S, Honrado E, Martínez-Ramírez A, Letón R, Montero-Conde C, Benítez J, Dopazo J, Cigudosa JC, Robledo M.

Genes Chromosomes Cancer. 2005 Mar;42(3):260-8.

PMID:
15609347
32.

ERBB2 and MYC alterations in BRCA1- and BRCA2-associated cancers.

Palacios J, Honrado E, Cigudosa JC, Benítez J.

Genes Chromosomes Cancer. 2005 Feb;42(2):204-5; author reply 206. No abstract available.

PMID:
15543618
33.

Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

Palacios J, Honrado E, Osorio A, Diez O, Rivas C, Benítez J.

J Natl Cancer Inst. 2004 May 5;96(9):712-4; author reply 714. No abstract available.

PMID:
15126609
34.

The pathology of hereditary breast cancer.

Honrado E, Benítez J, Palacios J.

Hered Cancer Clin Pract. 2004 Jul 15;2(3):131-8. doi: 10.1186/1897-4287-2-3-131.

35.

TNP-470 inhibits oxidative stress, nitric oxide production and nuclear factor kappa B activation in a rat model of hepatocellular carcinoma.

Mauriz JL, Linares P, Macias RI, Jorquera F, Honrado E, Olcoz JL, González P, González-Gallego J.

Free Radic Res. 2003 Aug;37(8):841-8.

PMID:
14567444
36.

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

Palacios J, Honrado E, Osorio A, Cazorla A, Sarrió D, Barroso A, Rodríguez S, Cigudosa JC, Diez O, Alonso C, Lerma E, Sánchez L, Rivas C, Benítez J.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3606-14.

PMID:
14506147
37.

Cost-effectiveness analysis of artesunate and quinine + tetracycline for the treatment of uncomplicated falciparum malaria in Chanthaburi, Thailand.

Honrado ER, Fungladda W, Kamoiratanaku P, Kitayaporn D, Karbwang J, Thimasarn K, Masngammueng R.

Bull World Health Organ. 1999;77(3):235-43.

38.

Compliance with artesunate and quinine + tetracycline treatment of uncomplicated falciparum malaria in Thailand.

Fungladda W, Honrado ER, Thimasarn K, Kitayaporn D, Karbwang J, Kamolratanakul P, Masngammueng R.

Bull World Health Organ. 1998;76 Suppl 1:59-66.

Supplemental Content

Loading ...
Support Center